News Content

Home   /  Recent News /  Tian Yuan advised Adagene Inc. to be listed on the Stock Exchange of the USA

Tian Yuan advised Adagene Inc. to be listed on the Stock Exchange of the USA

2021-02-09

On February 9, 2021 (USA Time), Adagene Inc., a platform-driven clinical phase biopharmaceutical company dedicated to the discovery and development of innovative antibody technology cancer immunotherapy, was officially listed on NASDAQ, the USA ( NASDAQ stock code: ADAG). Adagene Inc. initially issued 7,354,000 ADS at a price of US$19 per ADS, located at the upper limit of the offer price range. The opening price was about US$20.7, with a market value of nearly US$900 million. Goldman Sachs (Asia) L.L.C., Morgan Stanley &Co.LLC and Jefferies LLC acted as the joint account managers and underwriter representatives for this offering of Adagene Inc.. China Renaissance Securities (Hong Kong) Limited served as co-manager of this offering.


Scan QR code
Share the News

More real-time news
Please pay attention to the Tianyuan law firm WeChat public account
Long according to QR code, automatic identification of QR code.